MONDAY, Sept. 29, 2025 — The U.S. Food and Drug Administration (FDA) is reviewing the safety of mifepristone, a drug used in medication...
Vous n'êtes pas connecté
The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech executives, patient groups and conservative allies of President Donald Trump.
MONDAY, Sept. 29, 2025 — The U.S. Food and Drug Administration (FDA) is reviewing the safety of mifepristone, a drug used in medication...
PITTSBURGH, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States...
The Food and Drug Administration (FDA) announced that it has added another cinnamon product to its public...
The Food and Drug Administration (FDA) announced that it has added another cinnamon product to its public...
) FDA now concludes "the totality of evidence supports removal of the risk of fatal vaccine-induced disease from modified live virus vaccines...
) FDA now concludes "the totality of evidence supports removal of the risk of fatal vaccine-induced disease from modified live virus vaccines...
Replimune stock dives 54% over three months after the FDA rejects its RP1/Opdivo melanoma drug filing, delaying its first potential product launch.
TUESDAY, Sept. 23, 2025 — A decades-old cancer drug may soon be approved to help kids with certain autism-related symptoms linked to folate...
TUESDAY, Sept. 23, 2025 — A decades-old cancer drug may soon be approved to help kids with certain autism-related symptoms linked to folate...
Audience: Patient, Pharmacy, Health Care Professional September 25, 2025 -- The U.S. Food and Drug Administration today removed the Risk Evaluation...